Bioartificial liver system approved for clinical trials in China

Summary Bioartificial organ systems are becoming more attractive options for end‐stage organ disease. Currently, end‐stage liver disease has several palliative options but relies on transplantation for curative management. A new bioartificial liver has been approved for clinical trials in China and helps support the failed liver via stem cells.